Mabion

Mabion is a fully integrated CDMO located in central Europe. It was established in 2007 to develop and support the development of protein-based biotherapeutics, including monoclonal antibodies, vaccine antigens, and other large proteins. Mabion offers an “end-to-end” solution, covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process scale-up, large-scale manufacturing, and quality control down to sterile fill-finish, packaging and serialization, bioanalytics and regulatory support. A combination of broad capabilities and well-qualified, experienced staff makes Mabion a perfect long-term partner for any project involving therapeutic proteins, whether your product is in pre-clinical or clinical development or already commercially available.